INHIBITION OF THE ALTERNATIVE COMPLEMENT PATHWAY FOR TREATMENT OF TRAUMATIC BRAIN INJURY, SPINAL CORD INJURY AND RELATED CONDITIONS
摘要
<p>Disclosed is the use of agents and compositions that selectively inhibit the alternative complement pathway for the inhibiting or treating physiological damage resulting from traumatic brain injury (TBI), spinal cord injury (SCI), or related conditions. Preferred reagents for use in inhibition of damage resulting from TBI or SCI include those that inhibit factor B, with anti-factor B antibodies representing a particularly preferred agent.</p>
申请公布号
EP1885398(A4)
申请公布日期
2011.12.14
申请号
EP20060771303
申请日期
2006.05.26
申请人
THE REGENTS OF THE UNIVERSITY OF COLORADO;MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
发明人
HOLERS, VERNON, MICHAEL;THURMAN, JOSHUA, M.;TOMLINSON, STEPHEN;STAHEL, PHILIP, F.